Liusheng Wu
About
In The Last Decade
Liusheng Wu
20 papers receiving 371 citations
Hit Papers
Peers
Comparison fields: 5 of 49
- Pulmonary and Respiratory Medicine 169
- Oncology 137
- Molecular Biology 87
- Surgery 77
- Cancer Research 69
Countries citing papers authored by Liusheng Wu
This map shows the geographic impact of Liusheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liusheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liusheng Wu more than expected).
Fields of papers citing papers by Liusheng Wu
This network shows the impact of papers produced by Liusheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liusheng Wu. The network helps show where Liusheng Wu may publish in the future.
Co-authorship network of co-authors of Liusheng Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Liusheng Wu. A scholar is included among the top collaborators of Liusheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liusheng Wu. Liusheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 8 | |
| 5 | 0 | |
| 6 | 14 | |
| 7 | Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity breakdown → | 56 |
| 8 | 3 | |
| 9 | 42 | |
| 10 | 55 | |
| 11 | 51 | |
| 12 | 50 | |
| 13 | 2 | |
| 14 | Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma | 1 |
| 15 | Comparison of Double Sleeve Lobectomy by Uniportal Video-Assisted Thoracic Surgery (VATS) and Thoracotomy for NSCLC Treatment | 4 |
| 16 | 1 | |
| 17 | 10 | |
| 18 | Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer. | 26 |
| 19 | 4 | |
| 20 | Case report: renal lymphangiectasia. | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.